These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11440700)

  • 21. Reversible nucleoside analogue-associated lactic acidosis despite a prolonged course.
    Delobel P; Khatibi S; Alvarez M; Obadia M; Bonnet E; Massip P; Marchou B
    Intensive Care Med; 2003 Jun; 29(6):1028-1029. PubMed ID: 12684748
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
    Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature.
    Tripuraneni NS; Smith PR; Weedon J; Rosa U; Sepkowitz D
    AIDS Patient Care STDS; 2004 Jul; 18(7):379-84. PubMed ID: 15307926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
    Villalba N; Gómez-Cano M; Casas E; Soriano V; Valencia E; González-Lahoz J
    AIDS; 1997 Dec; 11(15):1896-7. PubMed ID: 9412717
    [No Abstract]   [Full Text] [Related]  

  • 28. Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis.
    Springer SA; Altice FL
    Clin Infect Dis; 2003 Jun; 36(12):e162-4. PubMed ID: 12802782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy.
    Shah I
    Ann Trop Paediatr; 2009 Dec; 29(4):257-61. PubMed ID: 19941748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine.
    Barreiro P; Soriano V; Valencia E; Díaz B; González-Lahoz J
    AIDS; 2001 Dec; 15(18):2469-70. PubMed ID: 11774839
    [No Abstract]   [Full Text] [Related]  

  • 33. Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs.
    Stojanov S; Wintergerst U; Belohradsky BH; Rolinski B
    AIDS; 2000 Jul; 14(11):1669. PubMed ID: 10983660
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.
    Crespo M; Ribera E; Suárez-Lozano I; Domingo P; Pedrol E; López-Aldeguer J; Muñoz A; Viladés C; Sánchez T; Viciana P; Teira R; García-Alcalde ML; Vergara A; Lozano F; Galindo MJ; Cosin J; Roca B; Terrón A; Geijo P; Vidal F; Garrido M;
    J Antimicrob Chemother; 2009 Jan; 63(1):189-96. PubMed ID: 18988678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
    Leeansyah E; Cameron PU; Solomon A; Tennakoon S; Velayudham P; Gouillou M; Spelman T; Hearps A; Fairley C; Smit de V; Pierce AB; Armishaw J; Crowe SM; Cooper DA; Koelsch KK; Liu JP; Chuah J; Lewin SR
    J Infect Dis; 2013 Apr; 207(7):1157-65. PubMed ID: 23303810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors].
    Moutschen M; Nkoghe D; Léonard P; Demonty J
    Rev Med Liege; 1997 Dec; 52(12):750-2. PubMed ID: 9481171
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lactic acidosis following antiretroviral therapy].
    Moreno-Cuerda VJ; Rubio García R
    Med Clin (Barc); 2005 Jul; 125(6):213-4. PubMed ID: 16022834
    [No Abstract]   [Full Text] [Related]  

  • 38. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.